Australia markets closed

Bausch Health Companies Inc. (BHCN.MX)

Mexico - Mexico Delayed price. Currency in MXN
Add to watchlist
185.000.00 (0.00%)
At close: 02:38PM CDT

Bausch Health Companies Inc.

2150 St. ElzEar Boulevard West
Laval, QC H7L 4A8

Sector(s):Β Healthcare
Industry:Β Drugs - Generic
Full-time employees:Β 19,600

Key executives

NameTitlePayExercisedYear born
Mr. Thomas J. AppioCEO & Director2.9MN/A1962
Mr. Robert A. SpurrU.S. Pres of Pharma Bus.1.48MN/A1962
Mr. Thomas G. VadakethExec. VP & CFON/AN/A1963
Mr. Mirza DautbegovicSr. VP & COON/AN/AN/A
Mr. Frederick J. MunschSr. VP, Controller & Chief Accounting OfficerN/AN/A1971
Dr. Robert F. ButzVP of Medical & Scientific AffairsN/AN/AN/A
Mr. Arthur J. ShannonSr. VP and Head of Investor Relations & Global CommunicationsN/AN/AN/A
Ms. Seana CarsonExec. VP & Gen. CounselN/AN/A1972
Ms. Kathleen FitzpatrickSr. VP & Chief HR OfficerN/AN/AN/A
Dr. Tage Ramakrishna M.D.Chief Medical Officer and Pres of R&DN/AN/A1974
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in MXN.


Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Corporate governance

Bausch Health Companies Inc.’s ISS governance QualityScore as of 1 May 2022 is 2. The pillar scores are Audit: 2; Board: 4; Shareholder rights: 4; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.